fr   en
Edition n°85 - 20 November 2008



Browse by date
Or search by keyword

Slide down articles / Slide up articles

Editorial
  • German Biotech companies show commitment
The stock market, fundraising and milestones
  • Good news from beyond the Rhine
  • Ares Life Sciences funding for Santhera
  • SEK 8 million for Pharmalink
Bioproduction
  • Merck Serono boosts its bioproduction
Industry and partners
  • Licensing agreements to follow BTG acquisitions
  • German company Ascenion acquires shares in US Certus Pharmaceuticals
Clinical trials
  • Encouraging results for Tripep therapeutic vaccine against hepatitis C
Vaccines
  • Therapeutic West Nile Virus vaccine
United Kingdom
  • Royal approval for new UK bioethics legislation
France
  • New scientific leads in treatment of obesity
In brief
  • IGEM 2008
  • GSK and Addex: the sequel
  • Zevtera® authorised in Switzerland
  • Solvay and Innogenetics
  • From Acambis to Vernalis